Clinical Trial Management System Market: Global Analysis of Key Manufacturers, Dynamics & Forecast 2022-2030 Global Market Insights recently introduced report on Global Clinical Trial Management System Market Report is an in-depth study providing complete analysis of the industry for the period 2022 to 2030. It provides complete overview of Global Clinical Trials industry considering all the major industry trends, market dynamics and competitive scenario. Notably, industry players have been adopting profitable strategies to improve their business presence, fostering the clinical trial management system (CTMS) market outlook. For instance, in June 2022, Medidata, a major provider of software as a service (SaaS) for clinical trials, introduced technology enhancements to its Medidata Detect and Rave CTMS to address concerns regarding clinical trial management and oversight. These enhancements were designed to improve both data reporting and oversight for contract research organizations and sponsors in the way they monitor as well as visualize trial data to enable faster decisionmaking. Browse key industry insights spread across 150 pages with 207 market data tables & 18 figures & charts from the report, “Clinical Trial Management System Market Analysis By Component (Software, Services), Product (Enterprise-based, Site-based), Delivery Mode (Web-based, Cloud-based, On Premise), By End-use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030” in detail along with the table of contents: https://www.gminsights.com/industryanalysis/clinical-trial-management-system-ctms-market In another notable development, in April 2022, Veeva Systems, a firm specializing in cloudbased solutions for pharmaceutical and life sciences applications, announced the global implementation of Veeva Vault CTMS by pharma behemoth Bristol Myers Squibb to drive end-to-end trial management. The new CTMS is integrated with Veeva's Study Startup and eTMF applications. The clinical trial management system market has been bifurcated on the basis of product, end-use, component, delivery mode, and region. From the product perspective, the market has been segregated into site based and enterprise based. The site based segment exceeded $334.7 million in revenue in 2021 and is expected to register significant growth in the upcoming time period. In terms of end-use, the market has been divided into clinical research organizations, pharmaceutical and biopharmaceutical companies, and others. In 2021, the clinical research organizations segment was valued at more than $407.7 million and is speculated to amass considerable gains over 2022-2030.
© 2022 All Rights Reserved
www.gminsights.com